Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Dessein

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Annals of the Rheumatic Diseases|October 16, 2008
Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritisM A Gonzalez-Gay, M T Garcia-Unzueta, A Berja, et al.
Autoimmunity Reviews|June 29, 2015
Prevention of cardiovascular disease in rheumatoid arthritisI Hollan, P H Dessein, N Ronda, et al.
Clinical and Experimental Rheumatology|September 19, 2008
High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritisM A Gonzalez-Gay, J Llorca, M T Garcia-Unzueta, et al.
Clinical and Experimental Rheumatology|June 21, 2008
Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritisM A Gonzalez-Gay, M T Garcia-Unzueta, C Gonzalez-Juanatey, et al.
Clinical and Experimental Rheumatology|May 29, 2009
Anti-TNF-alpha therapy does not modulate leptin in patients with severe rheumatoid arthritisM A Gonzalez-Gay, M T Garcia-Unzueta, A Berja, et al.
Clinical and Experimental Rheumatology|July 17, 2009
Short-term effect of anti-TNF-alpha therapy on nitric oxide production in patients with severe rheumatoid arthritisM A Gonzalez-Gay, M T Garcia-Unzueta, A Berja, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Annals of the Rheumatic Diseases|October 16, 2008
Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritisM A Gonzalez-Gay, M T Garcia-Unzueta, A Berja, et al.
Autoimmunity Reviews|June 29, 2015
Prevention of cardiovascular disease in rheumatoid arthritisI Hollan, P H Dessein, N Ronda, et al.
Clinical and Experimental Rheumatology|September 19, 2008
High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritisM A Gonzalez-Gay, J Llorca, M T Garcia-Unzueta, et al.
Clinical and Experimental Rheumatology|June 21, 2008
Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritisM A Gonzalez-Gay, M T Garcia-Unzueta, C Gonzalez-Juanatey, et al.
Clinical and Experimental Rheumatology|May 29, 2009
Anti-TNF-alpha therapy does not modulate leptin in patients with severe rheumatoid arthritisM A Gonzalez-Gay, M T Garcia-Unzueta, A Berja, et al.
Clinical and Experimental Rheumatology|July 17, 2009
Short-term effect of anti-TNF-alpha therapy on nitric oxide production in patients with severe rheumatoid arthritisM A Gonzalez-Gay, M T Garcia-Unzueta, A Berja, et al.
Pageof 4